These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19180802)
1. Anti-immunoglobulin responses to IgG, F(ab')2, and Fab botulinum antitoxins in mice. Mayers CN; Veall S; Bedford RJ; Holley JL Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):397-408. PubMed ID: 19180802 [TBL] [Abstract][Full Text] [Related]
2. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays. Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221 [TBL] [Abstract][Full Text] [Related]
3. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies. Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463 [TBL] [Abstract][Full Text] [Related]
4. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin. Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F. Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619 [TBL] [Abstract][Full Text] [Related]
6. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients. Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116 [TBL] [Abstract][Full Text] [Related]
7. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162 [TBL] [Abstract][Full Text] [Related]
8. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A. Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570 [TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo. Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311 [TBL] [Abstract][Full Text] [Related]
11. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics. Vázquez H; Olvera F; Alagón A; Sevcik C Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962 [TBL] [Abstract][Full Text] [Related]
12. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer. Endo K; Kamma H; Ogata T J Natl Cancer Inst; 1988 Aug; 80(11):835-42. PubMed ID: 3392743 [TBL] [Abstract][Full Text] [Related]
14. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens. Fjeld JG; Michaelsen TE; Nustad K Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231 [TBL] [Abstract][Full Text] [Related]
15. Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations. Torgeman A; Ozeri E; Ben David A; Diamant E; Rosen O; Schwartz A; Barnea A; Makovitzki A; Mimran A; Zichel R Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28555060 [TBL] [Abstract][Full Text] [Related]
16. Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus. Silvestris F; Yancey WB; Malone C; Searles R; Dammacco F; Williams RC Clin Immunol Immunopathol; 1991 May; 59(2):256-70. PubMed ID: 2009644 [TBL] [Abstract][Full Text] [Related]
18. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538 [TBL] [Abstract][Full Text] [Related]
19. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies. Klaus GG; Bijsterbosch MK; Parkhouse RM Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110 [TBL] [Abstract][Full Text] [Related]
20. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid. Al-Abdulla I; Casewell NR; Landon J J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]